ADAM 10 is associated with gastric cancer progression and prognosis of patients

Abstract

Expression of ADAM 10 in gastric cancer is significantly associated with lymph node and distant metastasis, high C-erbB-2 expression, and poor prognosis. ADAM 10 and C-erbB-2 proteins could be useful markers to predict tumor progression and prognosis.

Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review

“…Wang et al, 10 Song et al, 30 Pinto-de-Sousa et al, 34 Oshima et al 38 [6 Studies(2 studies between 1990 and 1999 not displayed)]…”

“…Wang et al, 10 Marx et al, 15 Song et al, 30 Garcia et al, 31 Ghaderi et al, 36 Oshima et al, 38 Allgayer et al 39 Wang et al, 10 Marx et al, 15 Zhang et al, 18 Potrc et al, 23 Garcia et al, 31 Ghaderi et al, 36 Wang et al, 37 Allgayer et al 39 Zhang et al, 18 Yu et al, 19 Potrc et al, 23 Park et al, 24 Lee et al, 32 Pinto-de-Sousa et al, 34 Ghaderi et al, 36 Allgayer et al 39 [11 Studies (3 studies between 1990 and 1999 not displayed)]…”

“…Advanced Wang et al, 10 Im et al, 27 Wang et al 37 [7 Studies (4 studies between 1990 and 1999 not displayed)]…”

“…N1/N2/N3 Wang et al, 10 Bazas et al, 14 Potrc et al, 23 Im et al 27 [10 Studies(6 studies between 1990 and 1999 not displayed)]…”

“…Not specified Wang et al, 10 Im et al 27 [2 Studies] Marx et al, 15 Yu et al, 19 Hayashi et al, 22 Satiroglu-Tufan et al, 25 Ghaderi et al, 36 Allgayer et al 39 15 Barros-Silva et al, 16 Hayashi et al, 22 Park et al, 24 Tanner et al, 26 Song et al, 30 Garcia et al, 31 Lee et al, 32 Pintode-Sousa et al, 34 Oshima et al 38 [12 Studies (2 studies between 1990 and 1999 not displayed)]…”